Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA | 9 | 2023 | 94 | 2.510 |
Why?
|
| Ribonucleoproteins | 7 | 2023 | 15 | 2.440 |
Why?
|
| RNA Interference | 8 | 2020 | 78 | 1.700 |
Why?
|
| RNA, Small Interfering | 7 | 2022 | 112 | 1.580 |
Why?
|
| Oligonucleotides, Antisense | 6 | 2019 | 24 | 1.500 |
Why?
|
| DNA Repeat Expansion | 4 | 2020 | 5 | 1.440 |
Why?
|
| Nucleic Acid Conformation | 9 | 2020 | 50 | 1.220 |
Why?
|
| Bacterial Proteins | 2 | 2021 | 93 | 1.200 |
Why?
|
| Microsatellite Repeats | 3 | 2020 | 22 | 1.190 |
Why?
|
| DNA | 5 | 2020 | 223 | 1.160 |
Why?
|
| Archaeal Proteins | 5 | 2012 | 5 | 1.110 |
Why?
|
| Cell Nucleus | 3 | 2016 | 111 | 0.910 |
Why?
|
| Amyotrophic Lateral Sclerosis | 4 | 2020 | 61 | 0.900 |
Why?
|
| Polymerase Chain Reaction | 3 | 2020 | 186 | 0.900 |
Why?
|
| Genetic Vectors | 2 | 2022 | 108 | 0.870 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 478 | 0.870 |
Why?
|
| Nucleic Acids | 2 | 2021 | 6 | 0.860 |
Why?
|
| Cloning, Molecular | 2 | 2022 | 74 | 0.820 |
Why?
|
| Base Sequence | 11 | 2020 | 252 | 0.810 |
Why?
|
| RNA, Double-Stranded | 3 | 2019 | 6 | 0.800 |
Why?
|
| RNA, Nuclear | 2 | 2014 | 2 | 0.790 |
Why?
|
| Monkeypox | 1 | 2023 | 1 | 0.790 |
Why?
|
| Frontotemporal Dementia | 3 | 2020 | 5 | 0.790 |
Why?
|
| RNA, Bacterial | 2 | 2019 | 3 | 0.730 |
Why?
|
| Endodeoxyribonucleases | 1 | 2021 | 1 | 0.720 |
Why?
|
| Ribose | 1 | 2021 | 1 | 0.720 |
Why?
|
| Gene Targeting | 2 | 2021 | 15 | 0.700 |
Why?
|
| Aptamers, Nucleotide | 1 | 2020 | 11 | 0.670 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2020 | 8 | 0.670 |
Why?
|
| Biological Assay | 1 | 2020 | 18 | 0.670 |
Why?
|
| Viral Proteins | 1 | 2020 | 30 | 0.660 |
Why?
|
| RNA, Archaeal | 3 | 2009 | 3 | 0.640 |
Why?
|
| Genome, Human | 2 | 2020 | 130 | 0.600 |
Why?
|
| Reference Standards | 1 | 2019 | 28 | 0.590 |
Why?
|
| Oligonucleotides | 3 | 2019 | 26 | 0.570 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 149 | 0.560 |
Why?
|
| Endonucleases | 1 | 2018 | 4 | 0.560 |
Why?
|
| Nerve Tissue Proteins | 5 | 2013 | 124 | 0.560 |
Why?
|
| Nuclear Proteins | 4 | 2011 | 74 | 0.560 |
Why?
|
| Proteins | 2 | 2016 | 149 | 0.550 |
Why?
|
| Huntington Disease | 5 | 2019 | 13 | 0.540 |
Why?
|
| G-Quadruplexes | 2 | 2020 | 9 | 0.540 |
Why?
|
| RNA, Antisense | 2 | 2016 | 3 | 0.510 |
Why?
|
| Humans | 26 | 2023 | 32274 | 0.500 |
Why?
|
| Molecular Mimicry | 1 | 2016 | 2 | 0.500 |
Why?
|
| RNA, Plant | 1 | 2016 | 2 | 0.500 |
Why?
|
| Metals | 1 | 2016 | 18 | 0.490 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 70 | 0.490 |
Why?
|
| Base Pair Mismatch | 1 | 2016 | 6 | 0.480 |
Why?
|
| RNA Editing | 1 | 2015 | 3 | 0.470 |
Why?
|
| Models, Molecular | 6 | 2020 | 204 | 0.470 |
Why?
|
| Methanococcales | 2 | 2012 | 2 | 0.450 |
Why?
|
| Molecular Biology | 1 | 2015 | 8 | 0.440 |
Why?
|
| Lead | 1 | 2015 | 4 | 0.440 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2012 | 15 | 0.440 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 19 | 0.440 |
Why?
|
| Autoantigens | 2 | 2014 | 15 | 0.440 |
Why?
|
| Cell Fractionation | 1 | 2014 | 8 | 0.430 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2014 | 3 | 0.430 |
Why?
|
| RNA-Binding Proteins | 2 | 2014 | 67 | 0.420 |
Why?
|
| Ribonuclease III | 1 | 2014 | 3 | 0.410 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 10 | 0.410 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 359 | 0.410 |
Why?
|
| Phylogeny | 3 | 2023 | 67 | 0.410 |
Why?
|
| Enzyme Inhibitors | 2 | 2011 | 174 | 0.400 |
Why?
|
| Methyltransferases | 2 | 2012 | 6 | 0.390 |
Why?
|
| Protein Binding | 6 | 2016 | 244 | 0.370 |
Why?
|
| Spermine | 1 | 2011 | 1 | 0.350 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2011 | 19 | 0.340 |
Why?
|
| Escherichia coli | 2 | 2020 | 88 | 0.320 |
Why?
|
| Amino Acid Sequence | 4 | 2020 | 290 | 0.310 |
Why?
|
| Recombinant Proteins | 2 | 2020 | 264 | 0.310 |
Why?
|
| RNA, Catalytic | 1 | 2009 | 1 | 0.300 |
Why?
|
| Streptococcus pyogenes | 2 | 2019 | 16 | 0.300 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2020 | 32 | 0.290 |
Why?
|
| DNA Cleavage | 2 | 2019 | 3 | 0.290 |
Why?
|
| Transcription, Genetic | 2 | 2020 | 140 | 0.280 |
Why?
|
| Hela Cells | 3 | 2020 | 72 | 0.260 |
Why?
|
| Models, Biological | 4 | 2011 | 408 | 0.260 |
Why?
|
| Promoter Regions, Genetic | 2 | 2020 | 203 | 0.250 |
Why?
|
| RNA, Small Nucleolar | 1 | 2006 | 1 | 0.250 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2006 | 4 | 0.250 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2020 | 63 | 0.240 |
Why?
|
| Structure-Activity Relationship | 2 | 2019 | 87 | 0.230 |
Why?
|
| Cytoplasm | 2 | 2016 | 29 | 0.220 |
Why?
|
| Animals | 6 | 2021 | 8199 | 0.220 |
Why?
|
| Gene Expression | 2 | 2020 | 345 | 0.220 |
Why?
|
| Protein Folding | 1 | 2023 | 31 | 0.200 |
Why?
|
| Disease Outbreaks | 1 | 2023 | 40 | 0.190 |
Why?
|
| Gene Knockdown Techniques | 1 | 2022 | 79 | 0.180 |
Why?
|
| Cell Line | 6 | 2015 | 454 | 0.180 |
Why?
|
| Pathology, Molecular | 1 | 2021 | 15 | 0.180 |
Why?
|
| Mutation | 3 | 2016 | 497 | 0.180 |
Why?
|
| Purine Nucleosides | 1 | 2020 | 1 | 0.170 |
Why?
|
| Pyrimidine Nucleosides | 1 | 2020 | 1 | 0.170 |
Why?
|
| Spermidine | 1 | 2020 | 2 | 0.170 |
Why?
|
| Subcellular Fractions | 1 | 2020 | 15 | 0.170 |
Why?
|
| Molybdenum | 1 | 2020 | 2 | 0.170 |
Why?
|
| Sodium Chloride | 1 | 2020 | 25 | 0.170 |
Why?
|
| Point Mutation | 1 | 2020 | 29 | 0.170 |
Why?
|
| Trinucleotide Repeats | 1 | 2020 | 9 | 0.170 |
Why?
|
| Magnesium | 1 | 2020 | 29 | 0.170 |
Why?
|
| Ink | 1 | 2020 | 11 | 0.170 |
Why?
|
| Disulfides | 1 | 2020 | 43 | 0.160 |
Why?
|
| Electrochemical Techniques | 1 | 2020 | 26 | 0.160 |
Why?
|
| DNA Restriction Enzymes | 1 | 2020 | 3 | 0.160 |
Why?
|
| Alleles | 2 | 2011 | 250 | 0.160 |
Why?
|
| Trinucleotide Repeat Expansion | 2 | 2010 | 3 | 0.160 |
Why?
|
| Repressor Proteins | 2 | 2011 | 50 | 0.160 |
Why?
|
| Drug Delivery Systems | 2 | 2011 | 104 | 0.150 |
Why?
|
| Oligonucleotide Probes | 1 | 2019 | 4 | 0.150 |
Why?
|
| Tandem Repeat Sequences | 1 | 2019 | 7 | 0.150 |
Why?
|
| DNA, A-Form | 1 | 2019 | 1 | 0.150 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 47 | 0.150 |
Why?
|
| Genotype | 1 | 2020 | 702 | 0.140 |
Why?
|
| Archaea | 2 | 2009 | 2 | 0.140 |
Why?
|
| Protein Structure, Secondary | 2 | 2016 | 59 | 0.140 |
Why?
|
| RNA Splicing | 1 | 2017 | 8 | 0.130 |
Why?
|
| Protein Structure, Tertiary | 3 | 2012 | 112 | 0.130 |
Why?
|
| Brassica | 1 | 2016 | 1 | 0.120 |
Why?
|
| Spinacia oleracea | 1 | 2016 | 1 | 0.120 |
Why?
|
| X-Ray Diffraction | 1 | 2016 | 4 | 0.120 |
Why?
|
| Catalysis | 2 | 2020 | 71 | 0.110 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2015 | 5 | 0.110 |
Why?
|
| Base Pairing | 1 | 2015 | 6 | 0.110 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2015 | 24 | 0.110 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 28 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2014 | 839 | 0.110 |
Why?
|
| RNA, Messenger | 2 | 2013 | 499 | 0.100 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2013 | 6 | 0.100 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 46 | 0.100 |
Why?
|
| Cyclooxygenase 2 | 1 | 2013 | 51 | 0.100 |
Why?
|
| RNA, Untranslated | 1 | 2013 | 10 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2011 | 74 | 0.100 |
Why?
|
| Binding Sites | 2 | 2011 | 144 | 0.100 |
Why?
|
| Peptide Nucleic Acids | 2 | 2011 | 4 | 0.100 |
Why?
|
| Cations | 1 | 2011 | 9 | 0.090 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2011 | 26 | 0.090 |
Why?
|
| Cell Membrane Permeability | 1 | 2011 | 19 | 0.090 |
Why?
|
| Giardia lamblia | 1 | 2011 | 2 | 0.090 |
Why?
|
| Molecular Structure | 1 | 2011 | 58 | 0.090 |
Why?
|
| Ribonucleoproteins, Small Nucleolar | 1 | 2011 | 4 | 0.090 |
Why?
|
| Protozoan Proteins | 1 | 2011 | 9 | 0.080 |
Why?
|
| Gene Transfer Techniques | 1 | 2011 | 60 | 0.080 |
Why?
|
| Phosphorothioate Oligonucleotides | 1 | 2010 | 1 | 0.080 |
Why?
|
| Ribonuclease H | 1 | 2010 | 7 | 0.080 |
Why?
|
| Circular Dichroism | 2 | 2011 | 39 | 0.080 |
Why?
|
| Models, Genetic | 1 | 2011 | 93 | 0.080 |
Why?
|
| Temperature | 2 | 2011 | 58 | 0.080 |
Why?
|
| RNA, Small Cytoplasmic | 1 | 2010 | 1 | 0.080 |
Why?
|
| 3' Untranslated Regions | 1 | 2010 | 25 | 0.080 |
Why?
|
| Leigh Disease | 1 | 2010 | 1 | 0.080 |
Why?
|
| Farnesyltranstransferase | 1 | 2010 | 2 | 0.080 |
Why?
|
| Ubiquinone | 1 | 2010 | 7 | 0.080 |
Why?
|
| Lysosomes | 1 | 2010 | 10 | 0.080 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 13 | 0.080 |
Why?
|
| Conserved Sequence | 1 | 2009 | 19 | 0.080 |
Why?
|
| Amino Acid Motifs | 1 | 2009 | 25 | 0.080 |
Why?
|
| Sirtuin 1 | 1 | 2010 | 36 | 0.080 |
Why?
|
| Sheep | 1 | 2010 | 194 | 0.080 |
Why?
|
| Phosphorylation | 1 | 2010 | 250 | 0.080 |
Why?
|
| Anthracenes | 1 | 2009 | 1 | 0.070 |
Why?
|
| Ethylene Glycols | 1 | 2009 | 7 | 0.070 |
Why?
|
| Sesquiterpenes | 1 | 2009 | 5 | 0.070 |
Why?
|
| Lactones | 1 | 2009 | 13 | 0.070 |
Why?
|
| Piperidines | 1 | 2010 | 137 | 0.070 |
Why?
|
| Pyridines | 1 | 2009 | 79 | 0.070 |
Why?
|
| Dopamine | 1 | 2010 | 262 | 0.070 |
Why?
|
| Methylation | 1 | 2006 | 7 | 0.060 |
Why?
|
| Chromatography, Affinity | 1 | 2006 | 15 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 1083 | 0.060 |
Why?
|
| Ferrocyanides | 1 | 2020 | 1 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2020 | 12 | 0.040 |
Why?
|
| Surface Properties | 1 | 2020 | 37 | 0.040 |
Why?
|
| Electrodes | 1 | 2020 | 20 | 0.040 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2020 | 2 | 0.040 |
Why?
|
| Luciferases, Firefly | 1 | 2020 | 2 | 0.040 |
Why?
|
| Carbohydrate Conformation | 1 | 2020 | 2 | 0.040 |
Why?
|
| Molecular Weight | 2 | 2011 | 55 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2020 | 16 | 0.040 |
Why?
|
| Particle Size | 1 | 2020 | 48 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 81 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 274 | 0.040 |
Why?
|
| Biosensing Techniques | 1 | 2019 | 24 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 98 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 93 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2015 | 143 | 0.030 |
Why?
|
| Histones | 1 | 2013 | 50 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 729 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2013 | 181 | 0.020 |
Why?
|
| Protein Stability | 1 | 2011 | 27 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2011 | 87 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2010 | 6 | 0.020 |
Why?
|
| BRCA1 Protein | 1 | 2010 | 6 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2010 | 31 | 0.020 |
Why?
|
| Chromatin | 1 | 2010 | 26 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2010 | 110 | 0.020 |
Why?
|
| Peptides | 1 | 2011 | 127 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2009 | 43 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2009 | 22 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2009 | 25 | 0.020 |
Why?
|
| Machado-Joseph Disease | 1 | 2009 | 1 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 314 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2009 | 119 | 0.020 |
Why?
|
| Mice | 1 | 2009 | 2571 | 0.010 |
Why?
|
| Male | 1 | 2009 | 19437 | 0.010 |
Why?
|
| Female | 1 | 2009 | 19942 | 0.010 |
Why?
|